Stay updated on Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.3, signaling a newer version of the study record. This update appears to be a metadata revision rather than a change to study content or functionality.
    Difference
    0.0%
    Check dated 2026-06-30T02:14:58.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has ended by stating 'No longer looking for participants' and adds sections to help readers read a study record, view common questions, and learn how to join. It also standardizes the Intervention/Treatment heading and notes the new revision version v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T22:01:38.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5, indicating a new version of the study record. This update does not modify the study text or results shown on the page.
    Difference
    0.0%
    Check dated 2026-06-08T17:46:16.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    A new CABOSUN trial citation was added to Publications with Revision: v3.5.4, and the prior Erratum entry (Revision: v3.5.3) was removed.
    Difference
    0.1%
    Check dated 2026-05-18T12:57:25.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page’s references section now shows an updated CABOSUN trial citation line including the associated erratum entries. The site footer revision/version tag was also updated from v3.5.0 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-27T07:57:36.000Z thumbnail image
  9. Check
    122 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No changes to study content are evident in the screenshot.
    Difference
    0.0%
    Check dated 2026-03-22T09:16:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.